DOI: 10.1055/s-00000071

Seminars in Neurology

References

Grossberg GT, Manes F, Allegri RF. , et al.
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.

CNS Drugs 2013;
27 (06) 469-478

Download Bibliographical Data

Access:
Access:
Access: